Probing structure-activity relationships in bactericidal peptide βpep-25

Biochemical Journal

Volumn 414, Issue 1, 2008, Pages 143-150

  Dings, Ruud P M ^a   Haseman, Judith R ^a   Mayo, Kevin H ^a  

^a University of Minnesota   (United States)

Author keywords

Bactericidal; Endotoxin neutralizing; Lipopolysaccharide; Peptide

Indexed keywords

ALKYLATION; AMINO ACIDS; BACTERIA; BACTERIOLOGY; BIOCHEMISTRY; DYES; ESCHERICHIA COLI; HEALTH; HYDROPHOBICITY; ORGANIC ACIDS; ORGANIC POLYMERS; POLYSACCHARIDES;

ACTIVITY PROFILING; ALKYL CHAIN LENGTHS; AMINO ACID RESIDUES; BACTERIAL MEMBRANES; BACTERIAL STRAINS; BACTERICIDAL; BACTERICIDAL ACTIVITIES; BIOACTIVE CONFORMATION; BUTYL GROUP; CATIONIC PEPTIDES; E. COLI; ENDOTOXIN NEUTRALIZING; EUKARYOTIC CELLS; GRAM-NEGATIVE BACTERIA; INFECTIOUS DISEASES; KLEBSIELLA PNEUMONIAE; LIPOPOLYSACCHARIDE; NORLEUCINE; NOVEL ANTIBIOTICS; OPTIMAL ACTIVITY; PEPTIDE; PS. AERUGINOSA; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA; SEROTYPE; SERRATIA MARCESCENS; SHEET STRUCTURES; STAPHYLOCOCCUS AUREUS; STRUCTURE-ACTIVITY RELATIONSHIPS;

AMINES;

ANTIMICROBIAL CATIONIC PEPTIDE; BETA PEP 25; BETA PEP 25 DERIVATIVE; LIPOPOLYSACCHARIDE; POLYPEPTIDE ANTIBIOTIC AGENT; ALANINE; BETAPEP 25 PROTEIN, SYNTHETIC; BETAPEP-25 PROTEIN, SYNTHETIC; PEPTIDE FRAGMENT; PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BETA SHEET; CONTROLLED STUDY; CYTOLYSIS; DISULFIDE BOND; DRUG SCREENING; DRUG STRUCTURE; ENZYME ACTIVITY; ESCHERICHIA COLI; EUKARYOTIC CELL; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN CELL; HYDROPHOBICITY; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHIMURIUM; SEQUENCE ANALYSIS; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION; AMINO ACID SUBSTITUTION; CHEMISTRY; COMPARATIVE STUDY; DRUG ANTAGONISM; GENETICS; GROWTH, DEVELOPMENT AND AGING; MOLECULAR GENETICS; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; EUKARYOTA; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SERRATIA MARCESCENS; STAPHYLOCOCCUS AUREUS;

ALANINE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIMICROBIAL CATIONIC PEPTIDES; ESCHERICHIA COLI; HUMANS; KLEBSIELLA PNEUMONIAE; LIPOPOLYSACCHARIDES; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEINS; PSEUDOMONAS AERUGINOSA; SALMONELLA TYPHIMURIUM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 49649110753     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20080506     Document Type: Article

References (43)

1. Lockwood, N. A. and Mayo, K. H. (2003) The future of antibiotics: bacterial membrane disintegrators. Drug Future 28, 911-923
2. Garcia-Olmedo, F., Molina, A., Alamillo, J. M. and Rodriguez-Palenzuela, P. (1998) Plant defense peptices. Biopolymers 47, 479-491
3. Otvos, Jr. L. (2000) Antibacterial peptides isolated from insects. J. Pept. Sci. 6, 497-511
4. Bulet, P., Hetru, C., Dimarcq, J. L. and Hoffmann, D. (1999) Antimicrobial peptides in insects; structure and function. Dev. Comp. Immunol. 23, 329-344
5. Simmaco, M., Mignogna, G. and Barra, D. (1998) Antimicrobial peptices from amphibian skin: what do they tell us? Biopolymers 47, 435-450
6. Ganz, T. and Weiss, J. (1997) Antimicrobial peptices of phagocytes and epithelia. Semin. Hematol. 34, 343-354
7. Ganz, T. and Lehrer, R. I. (1997) Antimicrobial peptides of leukocytes. Curr. Opin. Hematol. 4, 53-58
8. Levy, O. (2000) Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents. Blood 96, 2664-2672
9. Matsuzaki, K., Sugishita, K. Harada, M., Fujii, N. and Miyajima. K. (1997) Interactions of an antimicrobial peptice, magainin 2, with outer and inner membranes of Gram-negative bacteria. Biochim. Biophys. Acta 1327, 119-130
10. Andreu, D., Merrifield, R. B., Steiner, H. and Boman, H. G. (1985) N-terminal analogues of cecropin A: synthesis, antibacterial activity, and conformational properties. Biochemistry 24, 1683-1688
11. Reference deleted
12. Reference deleted
13. Lockwood, N. A., Haseman, J, R., Tirrell, M. V. and Mayo, K. H. (2004) Acylation of SC4 dodecaptide increases bactericidal potency against Gram-positive bacteria, including drug-resistant strains. Biochem. J. 378, 93-103
14. Matsuzaki, K., Yoneyama, S., Fujii, N., Miyajima, K., Yamada, K., Kirino, Y. and Anzai, K. (1997) Membrane permeabilization mechanisms of a cyclic antimicrobial peptide, tachyplesin I, and its linear analog. Biochemistry 36, 9799-9806
15. Carcillo, J. A. and Cunnion, R. E. (1997) Septic shock. Crit. Care Clin. 13, 553-574
16. Gagliardi, A. R., Hennig, B. and Collins, D. C. (1996) Antiestrogens inhibit endothelial cell growth stimulated by angiogenic growth factors. Anticancer Res. 16, 1101-1106
17. Rietschel, E. T., Brade, H., Hoist, O., Brade, L., Muller-Loennies, S., Mamat, U., Zahringer, U., Beckmann, F., Seydel, U., Brandenburg, K. et al. (1996) Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Curr. Top. Microbiol. Immunol. 216, 39-81
18. Trent, M. S., Stead, C. M., Tran, A. X. and Hankins, J. V. (2006) Diversity of endotoxin and its impact on pathogenesis. J. Endotoxin Res. 12, 205-223
19. Ulevitch, R. J. and Tobias, P. S. (1995) Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13, 437-457
20. Peschel, A. (2002) How do bacteria resist human antimicrobial peptides? Trends Microbiol. 10, 179-186
21. Mayo, K. H., Haseman, J., Ilyina. E. and Gray, B. (1998) Designed β-sheet-forming peptide 33mers with potent human bactericidal/ permeability increasing protein-like bactericidal and endotoxin neutralizing activities. Biochim. Biophys. Acta 1425, 81-92
22. Mayo, K. H., Ilyina, E. and Park, H. (1996) A recipe for designing water-soluble, β-sheet-forming peptides. Protein Sci. 5, 1301-1315
23. Griffioen, A. W., van der Schaff, D. W., Barendsz-Janson, A. F, Cox, A., Struijker Boudier, H. A., Hillen, H. F. and Mayo, K. H. (2001) Anginex, a designed peptide that inhibits angiogenesis. Biochem. J. 354, 233-242
24. Dings, R. P., Yokoyama, Y., Ramakrishnan, S., Griffioen, A. W. and Mayo, K. H. (2003) The designed angiostatic pepticle anginex synergistically improves chemotherapy and antiangiogenesis therapy with angiostatin. Cancer Res. 63, 382-385
25. Dings, R. P. Loren, M., Heun, H., McNiel, E., Griffioen, A. W., Mayo, K. H. and Griffin, R. J. (2007) Scheduling of radiation with angiogenesis inhibitors Anginex and Avastin improves therapeutic outcome via vessel normalization. Clin. Cancer Res. 13, 3395-3402
26. Dings, R. P., Williams, B. W., Song, C. W., Griffioen, A. W., Mayo, K. H. and Griffin, R. J. (2005) Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing enclothelial cells. Int. J. Cancer 115, 312-319
27. Dings, R. P. Laar, E. S., Webber, J., Zhang, Y., Griffin, R. J., Waters, S. J., Macdonald, J. R. and Mayo, K. H. (2008) Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven. Cancer Lett. 265, 270-280
28. Brandwijk, R. J., Dings, R. P., van der Linden, E., Mayo, K. H., Thiissen, V. L. and Griffioen, A. W. (2006) Anti-angiogenesis and anti-tumor activity of recombinant anginex. Biochem. Biophys. Res. Commun. 349, 1073-1078
29. Dings, R. P. and Mayo, K. H. (2007) A journey in structure-based drug discovery: from designed pepticles to protein surface topomimetics as antibiotic and antiangiogenic agents. Accounts Chem. Res. 40, 1057-1065
30. Homma, J. Y. (1976) A new antigenic schema and live-cell slide agglutination procedure for the infrasubspecific serologic classification of Pseudomonas aeruginosa. Jpn. J. Exp. Med. 46, 329-336
31. Warren, H. S., Novitsky, T. J., Bucklin, A., Kania, S. A. and Siber, G. R. (1987) Endotoxin neutralization with rabbit antisera to Escherichia coli J5 and other Gram-negative bacteria. Infect. Immun. 55, 1668-1673
32. Schlievert, P. M. and Blomster, D. A. (1983) Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J. Infect. Dis. 147, 236-242
33. Mayo, K. H., Haseman, J., Young, H. C. and Mayo, J. W. (2000) Structure-function relationships in novel peptide dodecamers with broad-spectrum bactericidal and endotoxin-neutralizing activities. Biochem. J. 349, 717-728
34. Chen, X., Dings, R. P., Nesmelova, I., Debbert, S., Haseman, J. R., Maxwell, J., Hoye, T. R. and Mayo, K. H. (2006) Topomimetics of amphipathic β-sheet and helix-forming bactericidal pepticles neutralize lipopolysaccharide enclotoxins. J. Med. Chem. 49, 7754-7765
35. Young, N. S., Levin, J. and Prendergast, R. A. (1972) An invertebrate coagulation system activated by endotoxin: evidence for enzymatic mediation. J. Clin. Invest. 51, 1790-1797
36. Arroyo, M. M. and Mayo, K. H. (2007) NMR solution structure of the angiostatic peptice anginex. Biochim. Biophys. Acta 1774, 645-651
37. Dings, R. P., Arroyo, M. M., Lockwood, N. A., Van Eijk, L. I., Haseman, J. R., Griffioen, A. W. and Mayo, K. H. (2003) β-Sheet is the bioactive conformation of the anti-angiogenic anginex pepticle. Biochem. J. 23, 281-288
38. Giangaspero, A., Sandri, L. and Tossi, A. (2001) Amphipathic a a helical antimicrobial peptides. Eur. J. Biochem. 268, 5589-5600
39. Ferguson, A. D., Hofmann, E., Coulton, J. W., Diederichs, K. and Welte, W. (1998) Siderophore-mediated iron transport: crystal structure of FhuA with bound lipopolysaccharide. Science 282, 2215-2220
40. Pristovsek, P. and Kidric, J. (1999) Solution structure of polymyxins B and E and effect of binding to lipopolysaccharide: an NMR and molecular modeling study. J. Med. Chem. 42, 4604-4613
41. Japelj, B., Pristovsek, R, Majerle, A. and Jerala, R. (2005) Structural origin of endotoxin neutralization and antimicrobial activity of a lactoterrin-based peptide. J. Biol. Chem. 280, 16955-16961
42. Pilch, J., Franzin, C. M., Knowles, L. M., Ferrer, F. J., Marassi, F. M. and Ruoslahti, E. (2006) The anti-angiogenic pepticle anginex disrupts the cell membrane. J. Mol. Biol. 355, 876-885
43. Thijssen, V. L., Postel, R., Brandwijk, R. J., Dings, R. P., Nesmelova, I., Satijn, S., Verhofstad, N., Nakabeppu, Y., Baum, L. G., Bakkers, J. et al. (2006) Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc. Natl. Acad. Sci. U.S.A. 103, 15975-15980